Restore Medical, a leader in interventional cardiology innovations, has achieved a significant milestone with the U.S. Food and Drug Administration’s (FDA) Breakthrough Device Designation for its pioneering ContraBand device. This designation underscores the potential of ContraBand to transform the treatment landscape for patients suffering from heart failure with reduced ejection fraction (HFrEF), who have not […]
Abbott has achieved a significant milestone in cardiac healthcare by securing the CE Mark for its AVEIR dual chamber (DR) leadless pacemaker system in Europe. This groundbreaking device represents the world’s first dual chamber leadless pacemaker, specifically designed to treat individuals with abnormal or slow heart rhythms—a condition affecting approximately 49 million people across the […]
In a significant development for cardiac care, Foldax Inc., a leading innovator in the field of polymer heart valve technology, has announced a manufacturing agreement with Dolphin Life Science India LLP. This partnership marks the first time the TRIA polymer mitral surgical heart valve will be manufactured outside of the United States, signaling a major […]
